. home.aspx



ViiV unveils emotional challenges related to HIV ART treatment

October 04, 2019 / Allie Nawrat

GSK’s ViiV Healthcare has presented results from its Positive Perspectives study examining the emotional challenges and burden of human immunodeficiency virus (HIV) antiretroviral therapy (ART) on people living with the condition. The study found that despite 87% of participants currently in treatment being satisfied with their present ART, there are still emotional challenges associated with the daily regimen of ART, with 66% saying taking daily ART was a constant reminder of their HIV status. Emotional challenges were particularly noteworthy for younger patients and those recently diagnosed. These groups reported more frequent concealment of medications – only 37% of the general group reported frequent concealing of medication, compared to 52% of both younger patients and those recently diagnosed. Younger patients and recently diagnosed patients also reported heightened stress and pressure from taking medications at the right time every day. The Positive Perspectives stud...